Skip to main content
Clinical Trials/NCT00957710
NCT00957710
Completed
Not Applicable

Slowing Language Decline in Progressive Aphasia Through Language Rehabilitation: Treatment and Neuroimaging Study

Baycrest1 site in 1 country7 target enrollmentAugust 2009

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
Primary Progressive Aphasia
Sponsor
Baycrest
Enrollment
7
Locations
1
Primary Endpoint
Accuracy of picture naming
Status
Completed
Last Updated
11 years ago

Overview

Brief Summary

Progressive aphasia is characterized by a steady and progressive loss of language skills in the presence of relatively preserved memory, attention, and thinking. The aim of this study is to slow the progression of language decline in progressive aphasia via language therapy. The first goal of this study is to improve naming abilities of individuals with progressive aphasia. This will be accomplished by carrying out an intensive treatment program for anomia. The second goal is to evaluate whether this intense language treatment re-activates affected areas and/or connections within the language network, using functional Magnetic Resonance Imaging (to measure neural activity in specific brain regions) and Diffusion Tensor Imaging tractography (to measure the connectivity between specific brain regions). This is the first study on progressive aphasia addressing both treatment and imaging in the same patients.

Registry
clinicaltrials.gov
Start Date
August 2009
End Date
December 2010
Last Updated
11 years ago
Study Type
Interventional
Study Design
Single Group
Sex
All

Investigators

Sponsor
Baycrest
Responsible Party
Principal Investigator
Principal Investigator

Regina Jokel

clinician scientist

Baycrest

Eligibility Criteria

Inclusion Criteria

  • Diagnosis of progressive aphasia
  • Native English speaker or fluent in English
  • Adequate hearing and vision (not requiring more than +6 diopter correction)
  • Willing and able to participate in each phase of the study (including two fMRI sessions)

Exclusion Criteria

  • Contraindications to fMRI (e.g., claustrophobia, pacemaker, ferromagnetic implant)
  • Current medical or psychiatric condition affecting cognition (other than progressive aphasia)

Outcomes

Primary Outcomes

Accuracy of picture naming

Time Frame: 3 months

Secondary Outcomes

  • Changes on neuroimaging(3 months)

Study Sites (1)

Loading locations...

Similar Trials